GUTS 10-Q: SEC filing
Fractyl Health, Inc.
Filed with the SEC on · accession 0001193125-26-458318
GUTS filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -7.8% by the first close after the filing.
Summary of the filing
Fractyl Health, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing details of its financing arrangements, including an at-the-market offering, warrants, and notes.
Key details
How GUTS stock reacted
Close before
$0.88
Nov 11, 2026
First close after
-7.84%
$0.81
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for GUTS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for GUTS?
Click hereFrequently asked questions
What did GUTS file with the SEC on Nov 12, 2026?
GUTS filed a 10-Q (SEC filing). Fractyl Health, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing details of its financing arrangements, including an at-the-market offering, warrants, and notes.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did GUTS stock react to this filing?
GUTS closed at $0.88 before the filing and $0.81 on Nov 12, 2026 (-7.84%).
Other GUTS SEC filings
- 8-K · SEC filingNov 12, 2026
- 8-K · Board changeNov 6, 2026
- 8-K · Executive departureOct 22, 2026
- 8-K · Fda approvalOct 16, 2026
- SCHEDULE 13G · SEC filingOct 13, 2026
- 8-K · Stock splitOct 1, 2026
- 8-K · Stock splitSep 24, 2026
- 8-K · Delisting noticeSep 11, 2026
- DEF 14A · Board changeAug 24, 2026
- 10-Q · SEC filingAug 10, 2026
Get alerts when GUTS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days